Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Fusion and Fission (1)
- Advanced Manufacturing (3)
- Biology and Environment (4)
- Clean Energy (19)
- Computer Science (1)
- Materials (37)
- Materials for Computing (5)
- National Security (22)
- Neutron Science (101)
- Nuclear Science and Technology (6)
- Quantum information Science (2)
- Supercomputing (21)
Date
News Topics
- (-) Neutron Science (2)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (6)
- Artificial Intelligence (2)
- Bioenergy (1)
- Biology (3)
- Biomedical (3)
- Buildings (1)
- Chemical Sciences (4)
- Composites (1)
- Computer Science (3)
- Coronavirus (1)
- Critical Materials (1)
- Decarbonization (2)
- Education (1)
- Energy Storage (4)
- Environment (2)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (1)
- Fusion (22)
- Grid (2)
- High-Performance Computing (4)
- Isotopes (1)
- ITER (6)
- Materials (1)
- Materials Science (4)
- Microscopy (1)
- Nanotechnology (1)
- Net Zero (1)
- Nuclear Energy (26)
- Partnerships (3)
- Physics (1)
- Security (2)
- Simulation (3)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (4)
- Transportation (2)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.